Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Genome and Company Announces Clinical Trial Collaboration with MSD to Evaluate 'GEN-001' in combination of KEYTRUDA® (pembrolizumab) in Phase 2 Clinical Trial in Biliary Tract Cancer Patients
Genome and Company (KOSDAQ: 314130, CEO∙CTO: Jisoo Pae∙Hansoo Park), a leading global microbiome anti-cancer drug […]
Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics
Oculis S.A., (Oculis) a global ophthalmology company developing life-changing treatments to save sight and improve […]
BioEcho Life Sciences Receives Growth Equity Investment from Ampersand Capital Partners
BioEcho Life Sciences GmbH, an innovative manufacturer of nucleic acid purification solutions for molecular diagnostics […]
Biohaven and Pfizer Receive Positive CHMP Opinion for Migraine Treatment
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) and Pfizer Inc. (NYSE: PFE) today announced that the Committee […]
Medicago and GSK Announce the Approval by Health Canada of COVIFENZ ®, an Adjuvanted Plant-based COVID-19 Vaccine
Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) today announced that Health […]
Abzena, Alira Health and Oncodesign Launch DRIVE™-Biologics to Support Access to Specialist Services from Discovery to Clinical Development for Oncology and Inflammation
Abzena, a partner research organization for integrated services from discovery through to clinical and commercial […]
Moderna and Thermo Fisher Scientific Announce Long-term Strategic Collaboration
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and […]
BioNTech and Medigene Announce Global Collaboration to Advance T Cell Receptor Immunotherapies Against Cancer
BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Medigene AG (FSE: MDG1, Prime Standard, “Medigene”), a clinical-stage immuno-oncology company focusing […]
GuideWell and Olive Debut First-Of-Its-Kind AI Solution to Accelerate Access to Health Care
GuideWell, a health solutions company and parent to the leading health insurer in Florida, and […]
Curve Therapeutics Announces Collaboration with MSD for Next Generation Drug Discovery Platform
Curve Therapeutics (Curve), a private biotechnology company pioneering a potentially game-changing, functional drug discovery platform, today […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more